Evidence map›Paper›PMID 12514100›Full record

ArticleGenes & development2003

Checkpoint activation regulates mutagenic translesion synthesis.

Mihoko Kai, Teresa S-F Wang

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 159 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. dNTP pool levels modulate mutator phenotypes of error-prone DNA polymerase ε variants.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  12. REV1 is important for the ATR-Chk1 DNA damage response pathway in Xenopus egg extracts.Biochemical and biophysical research communications · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mihoko KaiDepartment of Pathology, Stanford University School of Medicine, Stanford, California 94305-5324, USA.
Teresa S-F Wang
Stanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells have evolved checkpoint responses to arrest or delay the cell cycle, activate DNA repair networks, or induce apoptosis after genomic perturbation. Cells have also evolved the translesion synthesis processes to tolerate genomic lesions by either error-free or error-prone repair. Here, we show that after a replication perturbation, cells exhibit a mutator phenotype, which can be significantly affected by mutations in the checkpoint elements Cds1 and Rad17 or translesion synthesis polymerases DinB and Polzeta. Cells respond to genomic perturbation by up-regulation of DinB in a checkpoint activation-dependent manner. Moreover, association of DinB with chromatin is dependent on functional Rad17, and DinB physically interacts with the checkpoint-clamp components Hus1 and Rad1. Thus, translesion synthesis is a part of the checkpoint response.

Indexed as

DNA-Binding ProteinsEscherichia coli ProteinsMutagenesisProtein Serine-Threonine KinasesBacterial ProteinsCell CycleCell Cycle ProteinsCheckpoint Kinase 2ChromatinDNA-Directed DNA PolymeraseDNA Polymerase IDNA RepairDNA Repair EnzymesDNA ReplicationEndonucleasesGenes, cdcBacterial ProteinsCds1 protein, S pombeCell Cycle ProteinsCheckpoint Kinase 2ChromatinDinB protein, E coliDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA Polymerase IDNA polymerase zetaDNA Repair EnzymesEndonucleasesEscherichia coli Proteinshus1 protein, S pombeNuclear ProteinsProtein KinasesProtein Serine-Threonine KinasesRAD17 protein, S cerevisiaeRAD1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSchizosaccharomyces pombe Proteins

Identifiers

PMID12514100
PMCPMC195967
OpenAlexW2155953141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.